Revolutionizing drug discovery by Translating Big Data into pipeline drug candidates with a higher probability of success.
NuMedii is creating pipeline drug candidates with a higher probability of therapeutic success (PTS). The Company uses its Life Sciences Big Data technology to translate novel disease-drug connections into new indications for existing drugs and optimal indications for NMEs. NuMedii partners with pharmaceutical companies for the clinical development and commercialization of its de-risked drug candidates. Learn how.